Vinge advises Xintela

Vinge has advised Xintela in connection with the mandatory public offer from Flerie Invest AB.

Vinge advises Altor in connection with the investment in H2 Green Steel

Vinge represents Altor Fund V in connection with its investment in H2 Green Steel. The investment has been carried out in connection with H2 Green Steel's series B round totalling approx. EUR 190 million. Investors participating in the capital raise included, in addition to Altor, inter alia AMF, GIC, Swedbank Robur Alternative Equity, FAM and IMAS Foundation.

Vinge advises Semcon in connection with the offer from Etteplan

Vinge has advised Semcon AB (publ) in connection with a public takeover offer provided by Etteplan Oyj to the shareholders of Semcon. The offer prices SEK 149 per share and values Semcon AB approximately SEK 2 699.

Vinge advises in conjunction with the sale of Zington

Vinge has advised Sobro and other shareholders in conjunction with sale of Zington to VASS Group, a leading actor within digital transformation with its head office in Spain.

Vinge advises Active Biotech on rights offering

Active Biotech AB (publ) (Nasdaq Stockholm) carries out a rights issue of approximately SEK 55 million.

Vinge has advised 4 to 1 Investments, a company jointly held by Första AP-fonden, Andra AP-fonden, Tredje AP-fonden and Fjärde AP-fonden, in connection with Northvolt’s USD 1.1 billion convertible note

Vinge has advised 4 to 1 Investments in connection with Northvolt’s USD 1.1 billion convertible note, to finance its expansion of battery cell and cathode material production in Europe.

Vinge acted as advisor to Vimian Group (including VetFamily) on the acquisition of Heiland GmbH

Heiland.com is a leading online ordering platform offering veterinary pharmaceuticals, consumables, nutrition and more to veterinary clinics across Germany.

Vinge advises the founders of Future Media Group in conjunction with the sale to Caybon

Vinge has advised the founders Rikard Virta, Linus Wennerström and Johan Oscarsson as well as the other shareholders in conjunction with the sale of Future Media Group AB to Caybon.

Vinge advises Oncopeptides in connection with a directed share issue

The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncopeptides will raise proceeds of approximately SEK 435,6 million, before issue costs. The price per share in the share issue corresponds to the closing price on Nasdaq Stockholm the day of the share issue.

Vinge advises in conjunction with the merger between Retune and Tillmobil

Vinge has advised Sobro and the founders of Retune in conjunction with the establishment of a new group of companies which combine Retunes service offering within cloud-based infrastructure, security and consulting services with Tillmobils services within telephony, operator exchange services and hardware.

Vinge advices in conjunction with the sale of CityGlas

Corteco has acquired CityGlas, which offers glass and window construction services. Celero Capital has established Corteco in order to consolidate the Nordic market for renovation and maintenance of the exterior of properties.

Vinge advises Axcel in connection with the acquisition of Oral Care

Vinge advises Axcel in connection with the acquisition of Oral Care, a leading dental care provider in Sweden and Norway.

Vinge advises Marcegaglia Steel Group

Vinge advises Marcegaglia Steel Group, a leader in the steel processing sector, on the acquisition of the majority of Outokumpu’s Long Products business for 228 million euro.

Vinge has advised Odevo, a leading software and service company that serves the residential real estate market, in connection with its acquisition of Trinity Property Group.

Acting as a Swedish counsel, Vinge has together with Herbert Smith Freehills advised Odevo in connection with the acquisition.

Vinge has advised Studentbostäder i Norden AB (publ) in connection with a directed share issue

Vinge has advised Studentbostäder i Norden in connection with a directed share issue whereby the company receives SEK 125 million in issue proceeds before deduction of transaction costs.